AMTB
Amerant Bancorp Inc.
AMTB has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
AMTB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
AMTB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AMTB.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AMTB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.5x | $16.09 | -47% |
| Forward | 11x | $30.42 | — |
| Fair | 16x | $27.09 | -11% |
| Current | 18x | $30.42 | — |
| Expensive | 34x | $58.59 | +93% |
Historical ranges are pointers, not guarantees.
AMTB's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over AMTB in the historical PE scenario, which offers more potential upside but is not a forecast.
AMTB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
AMTB has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AMTB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.77 | +63% |
| Q3 2026 | $1.70 | -0.6% |
| Q2 2026 | $1.40 | +$1.47 |
| Q1 2026 | $1.42 | +$1.89 |
| Q4 2025 | $1.26 | +$1.70 |
| Q3 2025 | $1.71 | +$3.20 |
| Q2 2025 | -$0.07 | -112% |
| Q1 2025 | -$0.47 | -170% |
| Q4 2024 | -$0.44 | -146% |
AMTB's earnings per share have fallen from their peak: $1.70 over the past year, against $3.08 in early 2022.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over AMTB on earnings, with more consistent year-over-year improvement.
AMTB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $108.8M | -2.4% |
| Q2 2026 | $100.7M | -8.6% |
| Q1 2026 | $97.7M | -7.4% |
| Q4 2025 | $112.2M | +0.8% |
| Q3 2025 | $111.4M | +235% |
| Q2 2025 | $110.3M | +12% |
| Q1 2025 | $105.4M | +14% |
| Q4 2024 | $111.3M | +9.9% |
AMTB's revenue has slid since its 2021 peak: $109M last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | +14 points |
| Q2 2026 | 27% | -0.1 points |
| Q1 2026 | 23% | +8.9 points |
| Q4 2025 | 1.7% | -15 points |
| Q3 2025 | 17% | +203 points |
| Q2 2025 | 27% | +21 points |
| Q1 2025 | 15% | +0.1 points |
| Q4 2024 | 16% | +37 points |
AMTB's operating margin was 31% last quarter, up 14 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over AMTB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over AMTB on profitability, with a higher operating margin.
AMTB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $56.4M | +138% |
| Q2 2026 | $39.4M | -30% |
| Q1 2026 | $10.1M | -44% |
| Q4 2025 | $31.3M | -59% |
| Q3 2025 | $23.7M | +815% |
| Q2 2025 | $56.3M | +$60.1M |
| Q1 2025 | $18M | +$18.7M |
| Q4 2024 | $76.7M | +$93.6M |
AMTB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AMTB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -64.8K shares |
| 1 year | -5.6% | -2.3M shares |
| 3 years | +17% | +5.7M shares |
| 5 years | +4.6% | +1.8M shares |
| Available history | -7.3% | -3.1M shares |
AMTB has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2M |
| Q2 2026 | $16.4M |
| Q1 2026 | $18.7M |
| Q4 2025 | $13M |
| Q3 2025 | $10M |
| Q2 2025 | $5M |
| Q1 2025 | $5M |
| Q4 2024 | — |
AMTB spent $50M buying back its own shares over the past year, up 150% from the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AMTB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.0x | High |
| Q2 2026 | 8.9x | High |
| Q1 2026 | 8.7x | High |
| Q4 2025 | 9.5x | High |
| Q3 2025 | 9.2x | High |
| Q2 2025 | 93.7x | High |
| Q2 2024 | 24.6x | High |
| Q1 2024 | 20.9x | High |
AMTB's net debt is about 8.0 years of its operating earnings (EBITDA), down from 9.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like AMTB.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over AMTB on leverage, with a lower net debt burden relative to earnings.
AMTB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.2 | Neutral |
| Stochastic | 69.7 | Neutral |
AMTB's weekly RSI is 69 (neutral) and its Stochastic is 70 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AMTB PE vs Financial Services Sector
| Metric | AMTB | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 37% above |
| PE % | 55 | 63 | 8 pts below |
AMTB is trading at 18x earnings, a 37% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over AMTB on valuation relative to its sector.
AMTB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.6 | 2.7% above |
| 20 week MA | $28.8 | 5.6% above |
| 50 week MA | $24.7 | 23% above |
| 100 week MA | $22.2 | 37% above |
| 200 week MA | $22.0 | 39% above |
AMTB has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
AMTB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.8 | $15.2 | -30% |
| 2021 | $15.2 | $34.1 | +125% |
| 2022 | $34.1 | $27.0 | -21% |
| 2023 | $27.0 | $24.6 | -8.9% |
| 2024 | $24.6 | $22.3 | -9.1% |
| 2025 | $22.3 | $20.1 | -10% |
| 2026 YTD | $20.1 | $30.4 | +52% |
AMTB has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.